JPRN-C000000235未知未知
Efficacy of long term combination therapy of PEG-IFN-alpha-2b and Ribavirin for patients with chronic hepatitis C - Long term thrapy of PEG-IFN-alpha-2b and Ribavirin
Department of Hepatology, Graduate School of Medicine, Osaka City University0 个研究点目标入组 300 人开始时间: 2009年12月31日最近更新:
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Pregnant or lactating women and women who may be pregnant (2) Female patients or male patients with partners who may become pregnant who cannot practice contraception during treatment and 6 months after end of treatment (3) Male patients with pregnant partners who cannot comply with condom use during treatment and 6 months after end of treatment (4) History of hypersensitivity to ribavirin or other nucleoside analogs (5) Inadequately controlled cardiac disease (6) Hemoglobinopathy (7) Chronic renal failure or renal function disorder with creatinine clearance of 50 ml/min or less (8) With or with a history of severe psychosis such as severe depression, suicidal ideation or attempt, etc. (9) Serious hepatic function disorder (10) Autoimmune hepatitis (11) History of hypersensitivity to PEG-IFN alfa-2b or other interferons (12) History of hypersensitivity to biological products such as vaccine (13) Patients receiving shosaikoto (14) Judged by investigator to be not appropriate for inclusion in study
研究者
相似试验
招募中
不适用
Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in HCV Genotype 3 chronic hepatitis & compensated cirrhosis patientsHCV genotype 3 related chronic hepatitis & compensated cirrhosisSLCTR/2017/007Department of Hepatology Bangabandhu Sheikh Mujib Medical University
招募中
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and simeprevir(SMV) on patients with chronic hepatitis C - a multicenter studyChronic hepatitis CJPRN-UMIN000013749Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300
已完成
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and telaprevir(TVR) on patients with chronic hepatitis CChronic hepatitis CJPRN-UMIN000013743Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300
已完成
不适用
Efficasy of combination therapy PEG-IFN-alpha-2b and Ribavirin for patients with Serogroup1 and high titer HCV.Hepatitis CJPRN-C000000197Osaka university graduate school of medicine500
已完成
4 期
Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral roadchronic hepatitis CJPRN-UMIN000001170Gunma Liver Study Group220